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Although dispensing of medication has been addressed by theoretical models, studies that confirm 
the impact of this service are still needed. The objective was to evaluate the impact of a new model of 
medicine dispensing system on patients’ medication knowledge, adherence to treatment and satisfaction. 
One hundred and four patients attending the dispensing service of a community pharmacy between 21 
January 2013 and 20 April 2013 were included in this intervention study. The impact of the service on 
patients’ medication knowledge, adherence to treatment and satisfaction was assessed by using validated 
questionnaires at two time points: at the moment of medication dispensing and 30 days thereafter by 
telephone contact. Statistical analysis was performed by McNemar’s test, and a p<0.05 was set as 
statistically significant. The number of patients showing insufficient knowledge about medications 
decreased by 50% (p < 0.05), and the number of those showing sufficient knowledge was three times 
greater (p < 0.05) after medicine dispensing. A high level of satisfaction was observed. Improvement 
of medication adherence, however, was not observed. The proposed system model for drug dispensing 
improved patients’ knowledge about medication and satisfaction. 
Keywords: Community Pharmacy Services. Outcome Assessment (Health Care). Pharmacies. Patient 
Medication Knowledge. Patient Satisfaction. Brazil.
INTRODUCTION
In Brazil, similarly to European countries, medicine 
dispensing is a pharmaceutical practice that comprises 
dispensing of medication and counseling of patients 
(Brasil, 1998).
The main objective of drug dispensing practices is to 
promote an appropriate use of medications and to achieve 
the expected therapeutic success. They should consider 
cognitive aspects involved of prescription interpretation 
and provide the patients with individual guidance. 
(Angonesi, 2008; Foro de Atención Farmacéutica, 2007).
Several authors from Brazil and countries such as 
Portugal and Spain have proposed system models for 
drug dispensing that include both technical and cognitive 
approaches (Angonesi, Rennó, 2011; Cardoso et al., 2015; 
Foro de Atención Farmacéutica, 2007; Foro de Atención 
Farmacéutica, 2008; Soares et al., 2013). However, studies 
on medication dispensing have mostly focused on facility 
conditions and processes (Becker et al., 2007; Buurma et 
al., 2001; Chatsisvili et al., 2010; Indermitte et al., 2007; 
Sánchez, 2013), and further studies that investigate the 
impact of drug dispensing and proposed models are still 
needed.
According to Farris and Kirking (1993), the 
assessment of pharmaceutical care services, including drug 
dispensing, should be based on aspects other than clinical 
outcomes, since the role of the pharmacist in patient’s care 
encompasses more than clinical aspects. In addition to 
relieving symptoms and improving clinical parameters, the 
authors emphasize the importance of enhancing patients’ 
awareness about the therapy, adherence and satisfaction 
with health services.
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Considering the need for understanding the impact 
of pharmaceutical care provided during medication 
dispensing on patients, this study evaluated the results 
of a model proposed for drug dispensing in a community 
pharmacy in Brazil using three outcome measures: 
patients’ knowledge about medication, adherence to 
treatment and satisfaction with pharmaceutical services. 
METHOD
This was an intervention study performed at 
the University Pharmacy of the Federal University of 
Goias. This study was approved by the Research Ethics 
Committee of the Federal University of Goias (approval 
number 222/2012) and participants gave written informed 
consent before taking part.
Subjects
Patients attending the Division of drug dispensing 
of the University Pharmacy of the Federal University of 
Goias between 21 January 2013 and 20 April 2013 were 
considered eligible for the study. The follow-up period 
was defined based on therapeutical and epidemiological 
data of patients, who were composed mostly of chronic 
disease patients, who received their medication from the 
University Pharmacy for a 90-day treatment period. 
Inclusion criteria were attendance at the drug 
dispensing services, age greater than or equal to 18 
years and participants’ consent. Exclusion criteria were 
communication impairment, medication dispensed to 
individuals other than the patients or their caregivers, 
missing data in at least one evaluation time point, lack of 
informed consent. 
Setting characteristics 
In Brazil, University/Campus Pharmacies are 
pharmaceutical facilites aimed at drug dispensing and 
education, run by Pharmacy Schools (Conselho Federal 
de Farmácia, 2008).
Drug dispensing processes at the University 
Pharmacy of the Federal University of Goias (Cardoso et 
al., 2015; Ferreira et al., 2016) are conducted in continuing 
steps throughout patients receive personal and drug therapy 
information (Figure 1). This dispensing system model has 
been implemented in January 2012 in accordance with 
the National Policy of Pharmaceutical Assistance (Brasil, 
2004), previous publications (Angonesi, Rennó, 2011; 
Foro de Atención Farmacéutica, 2007; Iglésias-Ferreira, 
2009; Soares et al., 2013) and current legislation (Brasil, 
1973; 2009; Conselho Federal de Farmácia, 2001). After 
implementation of the system model, standard operating 
procedures were established.
It is worth pointing out that, since compounding 
drugs are also dispensed by the pharmacy, not all steps 
illustrated in Figure 1 are performed in the presence of 
the patient. Interpretation of prescription, for example, 
is generally conducted in the interval between the 
compounding drug order and its dispensing.
Medications were dispensed to patients or their 
caregivers. Drug prescription was carefully examined 
for its comformity to Brazilian regulations (Brasil, 
1973). Then, the patient was interviewed by a pharmacist 
regarding personal and therapy-related data: age, sex, 
height, weight, occupation, allergies and other chronic 
diseases, use of medications, smoking and drinking 
habits, pregnancy and lactation. Also, the pharmacist 
asked whether the patient was aware of the aim of the 
therapy, how to take the medications, and verified whether 
expected results of the therapy were being achieved as 
well as the occurrence of adverse effects. All data were 
stored in a dedicated software for pharmaceutical data 
management, Pharmacie (Pharmasoftware, 2013). Finally, 
the pharmacist interpreted the prescription according to 
the guideline proposed by the Grupo de Investigação 
em Cuidados Farmacêuticos da Universidade Lusófona, 
Portugal, (GICUF) (Iglésias-Ferreira, 2009) (Figure 2).
FIGURE 1 – Flowchart of drug dispensing processes routinely conducted at the University Pharmacy of the Federal University 
of Goias.
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In this pharmacotherapy assessment tool, the five 
questions showed in the flowchart were sequentially 
answered regarding each medication. When a drug-
related problem was identified (i.e. when the answer to 
any of these questions was no”), the assessment process 
was discontinued and the problem-solving process was 
initiated. According to the pharmacist’s discretion, each 
drug-related problem led to pharmaceutical interventions, 
followed by the reassessment of the therapy. These steps 
were successively repeated until the answers to all the 
questions were “yes”. Interventions could be addressed to 
the person who made the prescription, the patient or the drug 
in use, in accordance with the Pharmaceutical Care Network 
Europe classification of drug-related problem (Version 6.2) 
(PCNE, 2010). At the end of the pharmacotherapy analysis, 
the pharmacist evaluated whether the patient required other 
pharmaceutical services and referred the patient when 
deemed necessary. All drug- related problems identified 
and pharmaceutical services performed were registered in 
appropriate registration form. 
Medication was then dispensed and directions of 
the use were provided by the pharmacist as recommended 
by the International Pharmaceutical Federation (2009). 
Medication information was delivered orally or written.
FIGURE 2 – Flowchart of the pharmacotherapy analysis at the Campus Pharmacy.
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Data collection
Patients’ profile was characterized by sex, age, 
marital status, type of health service attended (public or 
private), and complexity of pharmacotherapy, obtained 
from the university pharmacy database (Pharmasoftware, 
2013). Complexity of pharmacotherapy was calculated 
using the Medication Regimen Complexity Index 
(Melchiors et al., 2007) and dichotomized into low 
(< 7 points) and high (≥ 7 points) (Fröhlich, Pizzol, 
Mengue, 2010). Patient’s knowledge about medication 
prescription and adherence behavior was assessed by 
appropriate questionnaires before and after the dispensing 
of medications, in a pretest-posttest design (Figure 3). 
Thirty days after dispensing of drugs, assessment 
questionnaires were administered by trained interviewers 
(and not by the same pharmacists at T0) to prevent 
interviewers’ bias. The most suitable time for the interview 
at T1 was scheduled at patients’ convenience. If the patient 
did not answer the first telephone call, two additional 
attempts were made on the two following days. When 
the third call was not answered, the patient was excluded 
from the study.
Adherence behavior was assessed by the Morisky 
scale questionnaire (Morisky, Green, Levine, 1986), and 
classified as adherence or non-adherence. Non-adherence 
was further divided by intentional and unintentional non-
adherence (Sewitch et al., 2003).
A validated questionnaire (Fröhlich, Pizzol, 
Mengue, 2010) was used to assess patients’ knowledge 
about medication. When more than one medication was 
dispensed, the questionnaire was asked regarding the first 
medication listed on the prescription. The first question 
(“What’s the name of the drug prescribed?”) was excluded 
from the evaluation, since the interviewer had to state 
which medicine the patient would be asked about. Final 
classification score was hence adapted and appropriately 
corrected to this exclusion. Patients’ knowledge about 
medication was classified in: (1) <7 points: insufficient 
(the patient cannot use medicines safely); (2) 7~9 points: 
moderate (the patient can use medicines safely in the 
absence of complications); (3) ≥ 10 points: good (the 
patient can use medicines safely in any circumstances).
Patients’ satisfaction with the drug dispensing service 
was assessed by an appropriate instrument validated in 
English (Larson, Rovers, MacKeigan, 2002) and translated 
into Portuguese (Correr et al., 2009). Patients were asked 
to fill in a Likert-type scale questionnaire concerning their 
satisfaction with the service (as ‘excellent’, ‘very good’, 
‘good’, ‘fair’ or ‘poor’).
Data analysis 
Data storage and analysis were performed using Epi 
Info 3.5.4 (Centers for Disease Control and Prevention, 
2012) and STATA Version 12 for Windows (StataCorp, 
2011). For statistical analyses, all variables were studied 
descriptively, by means of absolute and relative frequency 
calculations. Continuous variables were expressed as 
mean and standard deviation. 
Knowledge about drug prescription and adherence 
was assessed before and after drug dispensing by 
McNemar’s test. Knowledge about medication prescription 
was also assessed individually by chi-square and 
Fisher’s exact test. A p-value <0.05 was considered to be 
statistically significant. 
RESULTS
A total of 170 patients were included in the study. 
Forty-eight patients did not fill in the assessment 
instrument at T1, 16 patients did not return to the pharmacy 
for their ordered medication, and for two patients, the 
medication was not delivered due to issues related to the 
drug compounding process. A total of 104 completed the 
study. 
A high percentage of female patients with low 
complexity of pharmacotherapy were observed (Table I).
Compared with T0, adherence behavior was not 
significantly different, however the number of non-
adherent patients significantly (P=0.03) decreased at T1 
(Table II).
Knowledge about drug prescription improved 
significantly, with a 55% reduction in the number of 
patients with insufficient knowledge on medications. The 
number of patients with good knowledge on medication 
was more than three times greater at T1 compared with 
T0 (Table III). 
Comparative analyses of each parameter regarding 
knowledge revealed significant differences between T0 
and T1 (Table IV).
Patients reported a high level of satisfaction towards 
the dispensing service. All categories were rated as 
FIGURE 3 – Evaluation time points for assessing the drug 
dispensing service at the university pharmacy.
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excellent or very good by more than 70% of the patients, 
and the lowest mean rate, in a 5-point scale, was 4.3 
(Table V).
DISCUSSION
This study showed that the model for drug 
dispensation developed and used at the University 
Pharmacy of the Federal University of Goias increased the 
knowledge about safe use of medication in the absence of 
treatment-related complications in nearly 80% of patients 
that completed the study.
Our results are in line with previous studies 
conducted in Brazil and India (Oenning, Oliveira, Blatt, 
2011; Ponnusankar et al., 2004; Silva, Schenkel, Mengue, 
2000), showing increased knowledge about medications 
after dispensation. In comparison with other studies in 
Brazil (Oenning, Oliveira, Blatt, 2011; Silva, Schenkel, 
Mengue, 2000), a relatively greater percentage of 
patients with “good” knowledge on medication after drug 
dispensing were found in our study, however, similarly to 
their findings, we did not observe increased knowledge 
about adverse effects, skipping of doses or mode of drug 
administration. 
The lack of patients’ awareness of drug side effects 
has been discussed in previous studies (Oenning, Oliveira, 
Blatt, 2011; Silva, Schenkel, Mengue, 2000), which tend 
to conclude that it may be due to the lack of evaluation 
by the professionals responsible for drug prescription and 
dispensing, and also by the patients. Drug prescribers 
and pharmacists tend to omit information about drug 
adverse effects from the patients, in attempt to prevent 
non-adherence to treatment or symptoms caused by 
autosuggestion. 
Further studies describing determining factors of 
patients’ knowledge, concerning skipping doses and mode 
of administration of the drugs, after receiving pharmacist’s 
instructions are still needed. According to Margonato, 
Thomson and Paoliello (2008), only 23.5% of victims 
of unintentional drug poisoning received instructions 
on the correct use of medication at dispensation, as 
registered by a poison control center in Brazil. Lack of 
knowledge on medication may result in poor adherence, 
drug therapy failures, increased incidence of adverse 
effects, and aggravation of clinical conditions (Fernandes, 
Pires, Gouvêa, 2002; Margonato, Thomson, Paoliello, 
2008; Oenning, Oliveira, Blatt, 2011). On the other 
TABLE I – Characteristics of patients attending the medication 
dispensation division at the University Pharmacy of the Federal 
University of Goias, 2013 (n=104)
Variables n (%)
Sex
Female 84 (80.8)
Male 20 (19.2)
Age1
18 - 40 years 29 (29.9)
41 - 60 years 35 (36.1)
> 60 years 33 (34.0)
Marital status2 
Single 39 (42.9)
Married 32 (35.2)
Divorced 9 (9.9)
Widow/er 11 (12.0)
Type of health service3 
Public 47 (54.0)
Private 40 (46.0)
Attendance at the division of drug 
dispensation of the Pharmacy for  
the first time 
Yes 38 (36.5)
No 66 (63.5)
Complexity of the drug therapy 
High 20 (19.2)
Low 84 (80.8)
1.n = 97; 2.n = 91; 3.n=87
TABLE II – Patients adherence to drug therapy assessed by the Morisky scale questionnaire (Morisky< green, Levine, 1986) before 
and after the dispensation at the University Pharmacy of the Federal University of Goiás, 2013 (n = 104)
Levels of adherence
Before (T0) After (T1)
p*
n (%) n (%)
High level of adherence 17 (16.4) 18 (17.3) 0.81
Low level of adherence 87 (83.6) 86 (82.7)
Low unintentional adherence 18 (20.7) 25 (29.1) 0.18
Low intentional adherence 14 (16.1) 17 (19.8) 0.40
Intentional and Unintentional adherence 55 (63.2) 44 (51.1) 0.03
* McNemar’s Test
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hand, knowledge about medication is a key component 
of therapy success, as reported by Angelini et al. (2009) 
in a study demonstrating that improvement of patients’ 
knowledge on the management of inhaled corticosteroid 
during an education program was associated with patients’ 
clinical progress.
In this study, although we have not found an increase 
in adherence to treatment, intentional and unintentional 
non-adherence behavior has reduced. This finding 
suggests that dispensing of medication may not enhance 
adherence to treatment, but may induce a change in the 
non-adherence behavior, although this change was not 
statistically significant in our study.
Also, according to a review by Haynes et al. (2013), 
few dispensation-related interventions have been able to 
enhance adherence to pharmacotherapy. Additionally, 
although it is the mostly used indirect instrument to assess 
adherence, the Morisky scale also used in this study tends 
to overestimate non-adherence behavior, due to its strict 
criteria to classify the patient as ‘non-adherent’ (Leite, 
Vasconcellos, 2003).
Future studies using different methods for assessing 
adherence behavior and using a repeated measure design 
would be of great help in the understanding of the influence 
of dispensing service on adherence. 
Our dispensing system model promoted a high level 
of satisfaction by patients, which corroborates the findings 
reported in a similar study conducted in Spain (Guillén et 
al., 2012).
Studies measuring patient satisfaction with pharmacy 
services have shown that the human aspects of the services 
are the most influencing factor on patient satisfaction 
(Panvelkar, Saini, Armour, 2009). An implication of 
this finding is that, similarly to other studies in this field, 
satisfaction may be overestimated in our study, particularly 
taking into account that the patients interviewed were 
frequent users of the University Pharmacy.
Results of studies assessing patients’ satisfaction 
with health services should be seen with caution. 
Meeting or failing to meet patients’ expectation of care 
is an important predictor of patient satisfaction with the 
service (McKinley et al., 2002). In fact, the high level 
of satisfaction with medicine dispensing services might 
be resultant not from their good quality, but from a low 
expectation by the patients. This is reinforced by a study 
(Oenning, Oliveira, Blatt, 2011) showing that more than 
85% of patients were highly satisfied with dispensing 
of medications, even without receiving any information 
about the correct use of medicines. 
Patients’ satisfaction with pharmaceutical services is 
fundamental for the analysis of results, and correlates with 
the effectiveness of the activities performed. With respect 
to dispensing services, patients’ satisfaction can influence 
adherence to treatment and patient loyalty to the pharmacy, 
as highlighted by Guillén et al. (2012). 
TABLE III – Level of knowledge about medication before (T0) 
and after (T1) drug dispensation at the University Pharmacy of 
the Federal University of Goias, 2013 (n=104)
Level of 
knowledge
Before (T0)
n (%)
After (T1)
n (%) p*
Insufficient 43 (41.3) 23 (22.1) 0.00
Moderate 52 (50.0) 51 (49.0) 0.87
Good 9 (8.7) 30 (28.9) 0.00
*McNemar’s Test
TABLE IV – Comparison of level of knowledge before (T0) and after (T1) drug dispensation at the University Pharmacy of the 
Federal University of Goias, 2013 (n=104)
Questions about the 
drug prescribed 
Correct aswers Incorrect answers Did not know
p*T0
n (%)
T1
n (%)
T0
n (%)
T1
n (%)
T0
n (%)
T1
n (%)
Therapeutic indication 91 (87.5) 96 (92.3) 7 (6.7) 5 (4.8) 6 (5.8) 3 (2.9) 0.00**
Dosage 45 (43.3) 71 (68.3) 13 (12.5) 16 (15.4) 46 (44.2) 17 (16.3) 0.00
Times of administration 68 (65.4) 90 (86.6) 12 (11.5) 12 (11.5) 24 (23.1) 2 (1.9) 0.01**
Duration of treatment 70 (67.3) 80 (76.9) 9 (8.7) 5 (4.8) 25 (24.0) 19 (18.3) 0.01
Mode of administration 83 (79.9) 75 (73.1) 15 (14.4) 9 (8.6) 5 (4.8) 19 (18.3) 0.04
Skipping doses 79 (76.0) 62 (59.7) 9 (8.6) 7 (6.7) 16 (15.4) 35 (33.6) 0.02
Interactions 29 (27.9) 60 (57.7) 15 (14.4) 15 (14.4) 60 (57.7) 29 (27.9) 0.01
Adverse effects 31 (29.8) 49 (47.1) 15 (14.4) 23 (22.1) 58 (55.8) 32 (30.8) 0.21
* Chi-squared Test, ** Exact Fisher’s Test
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Questionnaires are the most frequently used 
instruments to assess satisfaction (Guillén et al., 
2012). Most of them, however, are self-developed, 
non-validated tools (Panvelkar, Saini, Armour, 2009), 
limiting the comparison of their results and utilization 
in other contexts (Panvelkar, Saini, Armour, 2009). In 
this study, we used a validated instrument, although the 
satisfaction with pharmacy services in general, rather 
than with dispensing services in particular was evaluated 
(Correr et al., 2009). 
The understanding of patients’ expectations of the 
dispensing service and whether the services meet these 
expectatios need to be explored. Also, future studies 
should investigate how patient’s satisfaction with a service 
influences the choice of the University Pharmacy, as well 
as the causes of dissatisfaction by the patients. 
Assessing the results of a drug dispensing service 
is a challenging issue, since the estimation of how 
drug dispensing affects the therapy main outcome, 
i.e., the clinical features, is considerably difficult 
TABLE V – Patient satisfaction with the drug dispensing service at the University Pharmacy of the Federal University of Goias, 2013
Questionnaire items Excellent/Very good (%) Good (%) Fair/Poor (%) Mean SD
1. Appearance of the Pharmacy* 79.8 18.3 1.9 4.39 0.82
2. Promptness of the pharmacist to answer your 
questions*
92.2 6.8 1.0 4.67 0.65
3. The pharmacist’s relationship with you* 91.3 7.7 1.0 4.71 0.60
4. The pharmacist’s ability to advise you about problems 
that you might have with your medication*
77.9 18.3 3.8 4.33 0.98
5. Promptness of drug prescription service** 87.2 10.8 2.0 4.52 0.80
6. Professionalism of the pharmacy staff** 94.1 4.9 1.0 4.68 0.62
7. How well the pharmacist explains what your 
medication do**
90.2 6.8 3.0 4.57 0.86
8. The pharmacist’s interest in your health ** 84.3 11.8 3.9 4.46 0.89
9. How well the pharmacist helps you to manage your 
medications*
85.4 13.6 1.0 4.48 0.76
10. The pharmacist’s efforts to solve problems that you 
have with your medications ***
89.1 9.9 1.0 4.55 0.71
11. The responsability taken by the pharmacist for your 
drug therapy ***
85.1 10.9 4.0 4.46 0.84
12. How well the pharmacist instructs you about how to 
take your medications ***
85.1 13.9 1.0 4.54 0.77
13. Your pharmacy services overall** 87.2 11.8 1.0 4.47 0.74
14. How well the pharmacist answers your questions 
****
87.0 12.0 1.0 4.54 0.74
15. The pharmacist’s efforts to help you improve your 
health or stay healthy**
79.4 18.6 2.0 4.41 0.86
16. Courtesy and respect shown by the pharmacy staff** 92.2 7.8 0.00 4.70 0.61
17. Privacy of the conversations between you and the 
pharmacist **
80.4 14.7 4.9 4.31 0.93
18. The pharmacist’s efforts to assure that your 
medications do what they are supposed to **
82.4 13.7 3.9 4.39 0.87
19. How well the pharmacist explains possible side 
effects **
76.5 18.6 4.9 4.32 1.03
20. The amount of time the pharmacist offers to spend 
with you **
80.4 16.7 2.9 4.35 0.86
*n=103; **n=102; ***n=101; ****n=100
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(Fernández-llimós, 2002). The knowledge about 
medications, adherence to treatment and satisfaction with 
pharmaceutical services may be considered surrogate 
endpoints in the assessment of dispensing practices. 
Surrogate endpoints can be measured relatively more 
easily and reflect the effects of the intervention on clinical 
endpoints (Wannmacher, 2010). They are used in clinical 
trials when the clinical endpoints are difficult to be 
assessed, and also to reduce sample size, time of follow-up 
and costs of the study (Coutinho, 2002).
CONCLUSION
These findings suggest that drug dispensing can 
enhance patients’ knowledge about drugs, by providing 
conditions for a correct the use of medications, in the 
absence of clinical complications. Additionally, drug 
dispensing promotes a high level of satisfaction by the 
patients, with no improvement of adherence behavior to 
the therapy though. 
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